Page Content
Publications 2006
- Busse R (2006): Health economics. Objectives, methodology, relevance - Gesundheitsschutz 49(1): 3-10
- Busse R, Schreyögg J, Gericke CA (2006): Financing health in high-income countries. In: Gottret P, Schieber G (eds.) Health Financing Revisited - A Practitioner's Guide. Washington, DC: World Bank, S. 279-310
- Busse R, Schreyögg J, Smith P (2006): Editorial: Hospital case payment systems in Europe. Health Care Management Science 9(3): 211-213
- Busse R, Zentner A, Schlette S (eds.) (2006): Health Policy Developments Issue 5: Focus on Public-Private Mix, Patient Safety, Public Health. Gütersloh: Bertelsmann Foundation Publishers
- Busse R, Zentner A, Schlette S (eds.) (2006): Health Policy Developments Issue 6: Focus on Evaluation, Continuum of Care, Information Technology. Gütersloh: Bertelsmann Foundation Publishers
- Allin S, Busse R, Dixon A, Figueras J, Mcdaid D, Mossialos E, Nolte E, Rico A, Riesberg A, Thomson S (2006): Health Systems in Transition Template. Copenhagen: European Observatory on Health Systems and Policies
- Auerbach H, Schreyögg J, Busse R (2006): Cost-effectiveness Analysis of Telemedical Devices for Pre-clinical Traffic Accident Emergency Rescue in Germany. Technology and Health Care 14(3): 189-197
- Gericke CA, Busse R, Sakowska I, Kuszewski K, Maciag A (2006): [Attempt to exclude invasive cardiology services in Poland – Rationing, national sovereignty and European Union law]. Przegl Epidemiol 60: 323-329
- Gericke CA (2006): Financing health care in Egypt: Current issues and options for reform. J Public Health (Berl); 14: 29-36
- Gericke CA, Schulte-Herbruggen O, Arendt T, Hellweg R (2006): Chronic alcohol intoxication in rats leads to a strong but transient increase in NGF levels in distinct brain regions.. J Neural Transm. 113(7): 813-20
- Grabka M, Schreyögg J, Busse R(2006):The impact of co-payments on patient behavior: evidence from a natural experiment
- Lange-Lindberg A-M, Velasco Garrido, Busse R (2006): Mistletoe treatments for minimising side effects of anticancer chemotherapy. GMS Health Tech
- Schreyögg J, Hollmeyer H, Staab D, Bluemel M, Busse R (2006): Hospitalization costs of cystic fibrosis – identifying homogenous cost-groups and determining predictors for cost variation. Pharmacoeconomics 24(10): 999-1009
- What makes the difference? Analysing methodologies to determine DRGs in nine European countries
- Schreyögg J, Tiemann O, Busse R (2006): Cost accounting to determine prices: how well do prices reflect costs in the German DRG-system? Health Care Management Science 9(3): 269-279
- Stargardt T, Schreyögg J (2006): The Impact of Cross-reference Pricing on Pharmaceutical Prices – Manufacturers’ Pricing Strategies and Price Regulation, Applied Health Economics and Health Policy, 5(4): 235-247
- Weinbrenner S, Busse R (2006): Germany. In: Rechel B , Dubois C-A, McKee M (eds.) The Health Care Workforce in Europe – Learning from experience. Copenhagen/ Brussels: European Observatory on Health Systems and Policies, S. 33-46
- Wismar M, Ernst K, Srivastava D, Busse R (2006): Health targets and (good) governance. EuroObserver 8(1): 1-5
- Wörz M, Foubister T, Busse R (2006): Access to health care in the EU Member States. EuroObserver 8(2): 1-4
Zusatzinformationen / Extras
Quick Access:
Schnellnavigation zur Seite über Nummerneingabe
Auxiliary Functions
- Font size:
